| PERIOD ENDING | 31-Mar-09 | 30-Nov-08 | 31-Aug-08 | 31-May-08 | | Total Revenue | 6,689,000 | 6,593,000 | 17,962,000 | 16,177,000 | | Cost of Revenue | 715,000 | 389,000 | (1,015,000) | 1,841,000 | | | Gross Profit | 5,974,000 | 6,204,000 | 18,977,000 | 14,336,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,362,000 | 4,790,000 | 7,116,000 | 3,223,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 1,272,000 |
-
|
-
| (346,000) | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,340,000 | 1,414,000 | 11,861,000 | 11,459,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 1,263,000 | (1,263,000) |
-
| | Earnings Before Interest And Taxes | 1,340,000 | 2,677,000 | 10,598,000 | 11,459,000 | | Interest Expense | 2,225,000 | 5,998,000 | 8,650,000 | 10,013,000 | | Income Before Tax | (885,000) | (3,321,000) | 1,948,000 | 1,446,000 | | Income Tax Expense | (695,000) | (1,155,000) | 531,000 | 439,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (190,000) | (2,195,000) | 1,425,000 | 1,026,000 | | | Non-recurring Events | | Discontinued Operations |
-
| (100,000) |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (190,000) | (2,295,000) | 1,425,000 | 1,026,000 | | Preferred Stock And Other Adjustments | 13,000 |
-
| (42,000) | 17,000 | | | Net Income Applicable To Common Shares | ($177,000) | ($2,372,000) | $1,383,000 | $1,043,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
